Clinical Trials Directory

Trials / Unknown

UnknownNCT01942421

Ocular Surface Reconstruction With Cultivated Autologus Mucosal Epithelial Transplantation

Ocular Surface Reconstruction With Cultivated Autologus Mucosal Epithelial Transplantation.

Status
Unknown
Phase
Phase 2 / Phase 3
Study type
Interventional
Enrollment
20 (estimated)
Sponsor
Mahidol University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to elucidate the appropriate condition of developing cultivated autologous oral mucosal epithelial graft and evaluate the surgical outcome of transplantation of the cultivated cells in the patients.

Detailed description

Ocular surface damage caused by severe ocular surface diseases. Corneal limbal stem cell transplantation has been demonstrated to improve the outcome of ocular surface reconstruction. However, the conventional management of allograft limbal transplantation generally has unsatisfactory outcome because of high risk of rejection and requires long-life immunosuppressive medications. Ocular surface reconstruction with cultivated autologous mucosal epithelial transplantation is served to improve the surgical results of ocular surface reconstruction and decrease the use of immunosuppressive medications

Conditions

Interventions

TypeNameDescription
PROCEDURECultivated mucosal epithelial transplantationcultivated autologous mucosal epithelium, then transplant to limbal stem cell deficiency patients.

Timeline

Start date
2008-01-01
Primary completion
2013-06-01
Completion
2013-12-01
First posted
2013-09-16
Last updated
2013-09-16

Locations

1 site across 1 country: Thailand

Source: ClinicalTrials.gov record NCT01942421. Inclusion in this directory is not an endorsement.